RACHAEL MCPEEK: Open Payments
NPI 1023642691 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 83 payments from 21 companies in 2025. Trend: 2023 $744 · 2024 $917 · 2025 $1,315
Food & beverage: $1,315
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $233 |
| Novo Nordisk Inc | 12 | $201 |
| Otsuka America Pharmaceutical, Inc. | 7 | $145 |
| Abbott Laboratories | 5 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 7 | $67 |
| Lilly USA, LLC | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| PFIZER INC. | 3 | $52 |
Products named: VRAYLAR, REXULTI, Ozempic, FREESTYLE LIBRE 3, TRINTELLIX, LEQVIO, VOQUEZNA, MOUNJARO.
Industry payments across IL — which companies pay providers there.
